Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
05/16/2025 | PUT | $95.00 | 6,515 | +4,528 | +227.88% |
05/16/2025 | PUT | $93.00 | 3,594 | +3,044 | +553.45% |
05/16/2025 | PUT | $90.00 | 6,866 | +2,627 | +61.97% |
05/16/2025 | CALL | $108.00 | 1,636 | +1,111 | +211.62% |
05/16/2025 | CALL | $100.00 | 1,701 | +1,096 | +181.16% |
05/16/2025 | PUT | $91.00 | 1,951 | +847 | +76.72% |
01/16/2026 | PUT | $67.50 | 2,393 | -10 | -0.42% |
05/23/2025 | CALL | $105.00 | 42 | -11 | -20.75% |
05/16/2025 | PUT | $110.00 | 317 | -19 | -5.65% |
06/20/2025 | PUT | $82.50 | 1,819 | -42 | -2.26% |
05/16/2025 | PUT | $105.00 | 1,525 | -69 | -4.33% |
05/16/2025 | CALL | $70.00 | 201 | -100 | -33.22% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.05% | 38.12M | 2.91B |
Income Fund of America Inc | 2.70% | 33.74M | 2.58B |
Vanguard 500 Index Fund | 2.32% | 28.99M | 2.21B |
Dodge & Cox Stock Fund | 2.02% | 25.19M | 1.92B |
Washington Mutual Investors Fund | 1.57% | 19.64M | 1.5B |
American Balanced Fund | 1.37% | 17.14M | 1.31B |
American Mutual Fund Inc | 1.33% | 16.67M | 1.27B |
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 16.4M | 1.25B |
Fidelity 500 Index Fund | 1.10% | 13.75M | 1.05B |
SPDR S&P 500 ETF Trust | 1.08% | 13.5M | 1.03B |
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
05/09 10:46 am
GlobeNewswire Inc.
Read moreNurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
04/28 04:00 pm
GlobeNewswire Inc.
Read moreGilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
04/21 02:49 pm
Benzinga
Read more2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around
04/17 05:45 am
The Motley Fool
Read more2 Top Dividend Stocks That Could Set You Up for Life
04/09 07:00 am
The Motley Fool
Read moreIs Vertex Pharmaceuticals Stock a Buy?
04/08 09:45 am
The Motley Fool
Read moreMinimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide
04/08 04:48 am
GlobeNewswire Inc.
Read more3 Stocks Leading Healthcare’s Comeback as Wall Street Turns Defensive
04/02 12:14 pm
Investing.com
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read moreBispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide
03/12 08:48 am
GlobeNewswire Inc.
Read moreThe Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)
03/11 04:20 am
The Motley Fool
Read moreNon-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight
02/26 02:00 pm
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education
02/24 11:00 am
GlobeNewswire Inc.
Read moreWhy Gilead Sciences Stock Is Jumping Today
02/12 01:21 pm
The Motley Fool
Read moreGilead Sciences Beats Q4 EPS Forecast
02/11 05:40 pm
The Motley Fool
Read more3 Fabulous Dividend Stocks to Buy in February
02/09 03:30 pm
The Motley Fool
Read moreThese 2 Dividend Stocks Are Absolute Bargains Right Now
02/08 09:30 am
The Motley Fool
Read more3 Top AI-Powered Biotech Stocks to Buy in February
02/06 10:45 am
The Motley Fool
Read moreGlobal Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica
01/17 04:30 am
GlobeNewswire Inc.
Read moreObesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
01/09 03:12 pm
Benzinga
Read moreNUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries
01/09 11:53 am
GlobeNewswire Inc.
Read moreGalapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
01/08 03:07 pm
Benzinga
Read moreGalapagos wil aandeelhouderswaarde ontgrendelen met voornemen tot splitsing in twee beursgenoteerde entiteiten
01/08 02:30 am
GlobeNewswire Inc.
Read moreBurkitt Lymphoma Global Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status
12/23 01:44 pm
GlobeNewswire Inc.
Read moreCancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology
12/09 08:10 am
Benzinga
Read moreCoccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report
12/04 08:00 am
GlobeNewswire Inc.
Read morePersonalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology
11/26 08:30 pm
Benzinga
Read morePersonalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology
11/26 08:30 pm
GlobeNewswire Inc.
Read moreNurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
11/17 11:30 am
GlobeNewswire Inc.
Read moreGilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
11/15 03:14 pm
Benzinga
Read more3 Spectacular High-Yield Dividend Stocks to Buy in November
11/10 10:30 am
The Motley Fool
Read moreMerus annonce ses résultats financiers pour le troisième trimestre 2024 et fait le point sur ses activités
11/02 06:18 am
GlobeNewswire Inc.
Read more3 Absurdly Cheap Stocks That Pay High Dividends
10/24 08:15 am
The Motley Fool
Read moreGilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
10/21 12:28 pm
Benzinga
Read moreAfter Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
10/18 02:34 pm
Benzinga
Read more3 Dirt Cheap Stocks to Buy Right Now
09/21 07:36 am
The Motley Fool
Read moreGot $200? 2 Healthcare Stocks to Buy and Hold Forever
09/14 08:45 am
The Motley Fool
Read moreWhy Gilead Sciences Stock Thrashed the Market Today
09/12 06:11 pm
The Motley Fool
Read moreGilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
09/12 01:46 pm
Benzinga
Read moreLiver Fibrosis Market Is Expected to Reach USD 43.98 Billion By 2030
09/02 04:15 pm
GlobeNewswire Inc.
Read moreGene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology
08/30 08:59 am
GlobeNewswire Inc.
Read moreBiologics Market Size to Surge to USD 855.8 Billion by 2031 with a 6.9% CAGR, Fueled by Advanced Targeting of Biological Pathways – Report by Transparency Market Research, Inc.
08/27 05:30 pm
GlobeNewswire Inc.
Read moreUK Patient's Perspective on the Corporate Reputation of Pharma, 2023-2024
08/20 11:52 am
GlobeNewswire Inc.
Read more3 Stocks Retirees Should Absolutely Love
08/10 06:50 am
The Motley Fool
Read moreBiotechnology Market Size and Growth | USD 4.25 Trillion by 2033
08/06 11:55 am
GlobeNewswire Inc.
Read moreMerus gibt die Finanzergebnisse für das zweite Quartal 2024 bekannt und informiert über den aktuellen Geschäftsverlauf
08/03 12:36 pm
GlobeNewswire Inc.
Read more2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
08/03 06:45 am
The Motley Fool
Read moreACTG Presents Data Analysis at AIDS 2024 Showing - GlobeNewswire
07/23 04:31 am
GlobeNewswire Inc.
Read more